TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Phanes Therapeutics’ PT217 receives FDA orphan drug designation for neuroendocrine carcinoma Phanes Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing oncology treatments, has achieved a significant milestone with… byPallavi MadhirajuAugust 18, 2024